Cell-Based Ophthalmic Therapies Global Market Report 2025

Description

Cell-based ophthalmic therapies are treatments for eye disorders that utilize living cells to repair, replace, or protect damaged ocular tissues. They address eye conditions that are challenging to treat with conventional approaches by promoting tissue regeneration and enhancing eye function. These therapies offer promising, long-lasting solutions for vision impairment and improve patients' eyesight and overall quality of life through advanced regenerative medicine.

The primary types of cell-based ophthalmic therapies include stem cell therapy, gene therapy, and tissue engineering. Stem cell therapy involves the use of stem cells to repair, replace, or regenerate damaged or diseased tissues and organs. It is applied in various conditions such as retinal disorders, corneal disorders, glaucoma, and more, and is utilized by hospitals, ophthalmic clinics, research institutes, and other end users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The cell-based ophthalmic therapies market research report is one of a series of new reports from The Business Research Company that provides cell-based ophthalmic therapies market statistics, including the cell-based ophthalmic therapies industry global market size, regional shares, competitors with the cell-based ophthalmic therapies market share, detailed cell-based ophthalmic therapies market segments, market trends, and opportunities, and any further data you may need to thrive in the cell-based ophthalmic therapies industry. This cell-based ophthalmic therapies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cell-based ophthalmic therapies market size has grown exponentially in recent years. It will grow from $1.22 billion in 2024 to $1.48 billion in 2025 at a compound annual growth rate (CAGR) of 21.1%. The growth during the historic period can be attributed to the increasing prevalence of eye disorders, rising demand for vision restoration, growing adoption of regenerative medicine, higher incidence of age-related degenerative conditions, and expanding investments in clinical trials.

The cell-based ophthalmic therapies market size is expected to see exponential growth in the next few years. It will grow to $3.14 billion in 2029 at a compound annual growth rate (CAGR) of 20.7%. The growth in the forecast period can be attributed to the increasing success of cell therapies, rising global healthcare expenditures, a growing geriatric population, an expanding pipeline of innovative products, and wider utilization of stem cells. Key trends during the forecast period include advancements in stem cell and gene-editing technologies, development of targeted drug delivery systems, innovations in regenerative medicine for retinal and corneal tissue restoration, improvements in biomaterials to enhance cell therapy safety and efficacy, and the establishment of international collaborations.

The rising prevalence of ophthalmic disorders is expected to drive the growth of the cell-based ophthalmic therapies market in the coming years. Ophthalmic disorders encompass conditions that affect eye health and vision, such as age-related macular degeneration, glaucoma, and diabetic eye disease. The prevalence of these disorders is increasing due to an aging population, which faces a higher risk of vision impairment and related complications as life expectancy rises. Cell-based ophthalmic therapies offer innovative solutions by repairing or replacing damaged retinal and ocular cells, promoting regeneration, restoring vision, and improving overall eye function. For example, in September 2023, the Association of Optometrists in the UK reported that England recorded 22,552 new vision impairment certifications in 2022, including 1,344 cases from diabetic eye disease, 3,614 from glaucoma, and 10,865 from age-related macular degeneration. Therefore, the growing burden of ophthalmic disorders is fueling market expansion for cell-based therapies.

Key players in the market are advancing treatments such as allogeneic cell therapy to address corneal endothelial diseases. Allogeneic cell therapy uses stem cells or other donor-derived cells from genetically distinct individuals of the same species to repair or replace damaged tissues. In September 2024, Aurion Biotech, Inc., a US-based clinical-stage biotechnology company, launched Vyznova (neltependocel) in Japan for the treatment of bullous keratopathy, a debilitating corneal endothelial disorder. Vyznova is believed to be the first approved allogeneic cell therapy specifically targeting corneal endothelial disease, securing both regulatory and reimbursement approvals in Japan.

In March 2025, Alcon Inc., a Switzerland-based eye care company, acquired a majority interest in Aurion Biotech, Inc. Through this acquisition, Alcon aims to advance Aurion's clinical-stage allogeneic cell therapy, AURN001, into Phase 3 development for corneal edema secondary to corneal endothelial disease, while expanding its ophthalmic pharmaceutical portfolio. Aurion Biotech develops advanced cell therapies aimed at treating eye disorders, reinforcing Alcon's commitment to innovative ophthalmic treatments.

Major players in the cell-based ophthalmic therapies market are F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Astellas Pharma Inc., Sumitomo Pharma Co. Ltd., Healios K.K., Lineage Cell Therapeutics, Pandorum Technologies Pvt. Ltd., ActualEyes Inc., Neurotech Pharmaceuticals Inc., Coave Therapeutics SAS, jCyte Inc., Eyestem Research Pvt. Ltd., Opsis Therapeutics, Regenerative Patch Technologies LLC, Emmetrope Ophthalmics LLC, GenSight Biologics S.A., MEDIPOST Co. Ltd., Riken, Luxa Biotechnology Inc.

North America was the largest region in the cell-based ophthalmic therapies market in 2024. The regions covered in cell-based ophthalmic therapies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cell-based ophthalmic therapies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell-based ophthalmic therapies market consists of revenues earned by entities by providing services such as clinical trial services, ocular cell therapy consultation, post-therapy monitoring and support, research and development services, and regulatory and compliance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell-based ophthalmic therapies market also includes sales of neural progenitor cell injections, bioengineered retinal pigment epithelium scaffolds, autologous mesenchymal stem cell grafts, and ex-vivo expanded conjunctival epithelial cell sheets. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell-Based Ophthalmic Therapies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell-based ophthalmic therapies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell-based ophthalmic therapies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell-based ophthalmic therapies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Therapy Type: Stem Cell Therapy; Gene Therapy; Tissue Engineering
2) By Application: Retinal Disorders; Corneal Disorders; Glaucoma; Other Applications
3) By End-User: Hospitals; Ophthalmic Clinics; Research Institutes; Other End-Users
Subsegment:
1) By Stem Cell Therapy: Embryonic Stem Cell Therapy; Mesenchymal Stem Cell Therapy; Induced Pluripotent Stem Cell Therapy; Retinal Pigment Epithelium Cell Therapy; Limbal Stem Cell Therapy
2) By Gene Therapy: Viral Vector-Based Gene Therapy; Non-Viral Vector Based Gene Therapy; In-Vivo Gene Therapy; Ex-Vivo Gene Therapy; Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Based Gene Therapy
3) By Tissue Engineering: Bioengineered Corneal Tissue; Amniotic Membrane Transplantation; Hydrogel-Based Scaffolds; Synthetic Polymer Scaffolds; Decellularized Tissue Constructs
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Bayer AG; Novartis AG; Astellas Pharma Inc.; Sumitomo Pharma Co. Ltd.; Healios K.K.; Lineage Cell Therapeutics; Pandorum Technologies Pvt. Ltd.; ActualEyes Inc.; Neurotech Pharmaceuticals Inc.; Coave Therapeutics SAS; jCyte Inc.; Eyestem Research Pvt. Ltd.; Opsis Therapeutics; Regenerative Patch Technologies LLC; Emmetrope Ophthalmics LLC; GenSight Biologics S.A.; MEDIPOST Co. Ltd.; Riken; Luxa Biotechnology Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37717

1. Executive Summary

2. Cell-Based Ophthalmic Therapies Market Characteristics

3. Cell-Based Ophthalmic Therapies Market Trends And Strategies

4. Cell-Based Ophthalmic Therapies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cell-Based Ophthalmic Therapies Growth Analysis And Strategic Analysis Framework

5.1. Global Cell-Based Ophthalmic Therapies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Cell-Based Ophthalmic Therapies Market Growth Rate Analysis
5.4. Global Cell-Based Ophthalmic Therapies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Cell-Based Ophthalmic Therapies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Cell-Based Ophthalmic Therapies Total Addressable Market (TAM)

6. Cell-Based Ophthalmic Therapies Market Segmentation

6.1. Global Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Stem Cell Therapy
Gene Therapy
Tissue Engineering
6.2. Global Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Retinal Disorders
Corneal Disorders
Glaucoma
Other Applications
6.3. Global Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Ophthalmic Clinics
Research Institutes
Other End-Users
6.4. Global Cell-Based Ophthalmic Therapies Market, Sub-Segmentation Of Stem Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Embryonic Stem Cell Therapy
Mesenchymal Stem Cell Therapy
Induced Pluripotent Stem Cell Therapy
Retinal Pigment Epithelium Cell Therapy
Limbal Stem Cell Therapy
6.5. Global Cell-Based Ophthalmic Therapies Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Viral Vector Based Gene Therapy
Non-Viral Vector Based Gene Therapy
In-Vivo Gene Therapy
Ex-Vivo Gene Therapy
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Based Gene Therapy
6.6. Global Cell-Based Ophthalmic Therapies Market, Sub-Segmentation Of Tissue Engineering, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bioengineered Corneal Tissue
Amniotic Membrane Transplantation
Hydrogel-Based Scaffolds
Synthetic Polymer Scaffolds
Decellularized Tissue Constructs

7. Cell-Based Ophthalmic Therapies Market Regional And Country Analysis

7.1. Global Cell-Based Ophthalmic Therapies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Cell-Based Ophthalmic Therapies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell-Based Ophthalmic Therapies Market

8.1. Asia-Pacific Cell-Based Ophthalmic Therapies Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell-Based Ophthalmic Therapies Market

9.1. China Cell-Based Ophthalmic Therapies Market Overview
9.2. China Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell-Based Ophthalmic Therapies Market

10.1. India Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell-Based Ophthalmic Therapies Market

11.1. Japan Cell-Based Ophthalmic Therapies Market Overview
11.2. Japan Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell-Based Ophthalmic Therapies Market

12.1. Australia Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell-Based Ophthalmic Therapies Market

13.1. Indonesia Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell-Based Ophthalmic Therapies Market

14.1. South Korea Cell-Based Ophthalmic Therapies Market Overview
14.2. South Korea Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell-Based Ophthalmic Therapies Market

15.1. Western Europe Cell-Based Ophthalmic Therapies Market Overview
15.2. Western Europe Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell-Based Ophthalmic Therapies Market

16.1. UK Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell-Based Ophthalmic Therapies Market

17.1. Germany Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell-Based Ophthalmic Therapies Market

18.1. France Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell-Based Ophthalmic Therapies Market

19.1. Italy Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell-Based Ophthalmic Therapies Market

20.1. Spain Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell-Based Ophthalmic Therapies Market

21.1. Eastern Europe Cell-Based Ophthalmic Therapies Market Overview
21.2. Eastern Europe Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell-Based Ophthalmic Therapies Market

22.1. Russia Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell-Based Ophthalmic Therapies Market

23.1. North America Cell-Based Ophthalmic Therapies Market Overview
23.2. North America Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell-Based Ophthalmic Therapies Market

24.1. USA Cell-Based Ophthalmic Therapies Market Overview
24.2. USA Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell-Based Ophthalmic Therapies Market

25.1. Canada Cell-Based Ophthalmic Therapies Market Overview
25.2. Canada Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell-Based Ophthalmic Therapies Market

26.1. South America Cell-Based Ophthalmic Therapies Market Overview
26.2. South America Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell-Based Ophthalmic Therapies Market

27.1. Brazil Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell-Based Ophthalmic Therapies Market

28.1. Middle East Cell-Based Ophthalmic Therapies Market Overview
28.2. Middle East Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell-Based Ophthalmic Therapies Market

29.1. Africa Cell-Based Ophthalmic Therapies Market Overview
29.2. Africa Cell-Based Ophthalmic Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Cell-Based Ophthalmic Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Cell-Based Ophthalmic Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell-Based Ophthalmic Therapies Market Competitive Landscape And Company Profiles

30.1. Cell-Based Ophthalmic Therapies Market Competitive Landscape
30.2. Cell-Based Ophthalmic Therapies Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sumitomo Pharma Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Cell-Based Ophthalmic Therapies Market Other Major And Innovative Companies

31.1. Healios K.K.
31.2. Lineage Cell Therapeutics
31.3. Pandorum Technologies Pvt. Ltd.
31.4. ActualEyes Inc.
31.5. Neurotech Pharmaceuticals Inc.
31.6. Coave Therapeutics SAS
31.7. jCyte Inc.
31.8. Eyestem Research Pvt. Ltd.
31.9. Opsis Therapeutics
31.10. Regenerative Patch Technologies LLC
31.11. Emmetrope Ophthalmics LLC
31.12. GenSight Biologics S.A.
31.13. MEDIPOST Co. Ltd.
31.14. Riken
31.15. Luxa Biotechnology Inc.

32. Global Cell-Based Ophthalmic Therapies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell-Based Ophthalmic Therapies Market

34. Recent Developments In The Cell-Based Ophthalmic Therapies Market

35. Cell-Based Ophthalmic Therapies Market High Potential Countries, Segments and Strategies

35.1 Cell-Based Ophthalmic Therapies Market In 2029 - Countries Offering Most New Opportunities
35.2 Cell-Based Ophthalmic Therapies Market In 2029 - Segments Offering Most New Opportunities
35.3 Cell-Based Ophthalmic Therapies Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer